Changing trends in the use of novel oral anticoagulants and warfarin for treating non-valvular atrial fibrillation.

Alexander BirkinshawChristopher H FryDavid FluckPankaj SharmaThang Sieu Han

Published in: JRSM cardiovascular disease (2020)

Changing trends in treatment with anticoagulants for patients with non-valvular atrial fibrillation observed within less than two years provide important information to healthcare services to estimate future pharmaco-economic costs for such treatments.

Keyphrases

oral anticoagulants
atrial fibrillation
healthcare
catheter ablation
left atrial
left atrial appendage
direct oral anticoagulants
primary care
heart failure
percutaneous coronary intervention
health information
mental health
current status
left ventricular
social media